ABVC
ABVC
NASDAQ · Biotechnology

Abvc Biopharma Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.98
+0.02 (+1.60%)
As of Nov 14, 2:38 AM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +2,423.0% upside
Low Target $17.28
Average Target $24.70
High Target $43.03
Current Price $0.98
Current
$0.98
Target
$24.70
$17.28 $24.70 avg $43.03
Scenario Analysis
Bear Case
$17.28
1,665.1%
Low target
Base Case
$24.70
+2,423.0%
Avg target
Bull Case
$43.03
+4,295.3%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$3.06
-68.0% from high
52-Week Low
$0.71
+38.5% from low
Target vs 52W High
$24.70
+707.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
 Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
 Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
 Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
 Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
 Strong Buy 31 94% $114.11 -33.8%